These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7678701)

  • 21. Regulation of c-Fgr protein kinase by c-Src kinase (CSK) and by polycationic effectors.
    Ruzzene M; James P; Brunati AM; Donella-Deana A; Pinna LA
    J Biol Chem; 1994 Jun; 269(22):15885-91. PubMed ID: 7515063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divalent ion effects and insights into the catalytic mechanism of protein tyrosine kinase Csk.
    Grace MR; Walsh CT; Cole PA
    Biochemistry; 1997 Feb; 36(7):1874-81. PubMed ID: 9048573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
    Barnes H; Ackermann EJ; van der Geer P
    Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P; Cannella MT; Shalloway D
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine 170 is dispensable for c-Jun turnover.
    Xie M; Sabapathy K
    Cell Signal; 2010 Feb; 22(2):330-7. PubMed ID: 19818398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of C-terminal src kinase in human colorectal cancer cell lines.
    Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
    Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
    Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
    Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro.
    Tanaka A; Salem M; Eckroade RJ; Fujita DJ
    Oncogene Res; 1990; 5(4):305-22. PubMed ID: 2168536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
    Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
    Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Src family of protein tyrosine kinases: regulation and functions.
    Courtneidge SA; Fumagalli S; Koegl M; Superti-Furga G; Twamley-Stein GM
    Dev Suppl; 1993; ():57-64. PubMed ID: 8049488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RACK1: a novel substrate for the Src protein-tyrosine kinase.
    Chang BY; Harte RA; Cartwright CA
    Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSK: a protein-tyrosine kinase involved in regulation of src family kinases.
    Okada M; Nada S; Yamanashi Y; Yamamoto T; Nakagawa H
    J Biol Chem; 1991 Dec; 266(36):24249-52. PubMed ID: 1722201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of autophosphorylation in modulation of erbB-2 transforming function.
    Segatto O; Lonardo F; Pierce JH; Bottaro DP; Di Fiore PP
    New Biol; 1990 Feb; 2(2):187-95. PubMed ID: 1982072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of p60c-src with polyoma virus middle-T antigen abrogating mitosis-specific activation.
    Kaech S; Covic L; Wyss A; Ballmer-Hofer K
    Nature; 1991 Apr; 350(6317):431-3. PubMed ID: 1707141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of c-Src in cells bearing v-Crk and its suppression by Csk.
    Sabe H; Okada M; Nakagawa H; Hanafusa H
    Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Csk phosphorylation and inactivation in vitro by the cAMP-dependent protein kinase.
    Sun G; Ke S; Budde RJ
    Arch Biochem Biophys; 1997 Jul; 343(2):194-200. PubMed ID: 9224730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Src homology 2 domain deletion mutants of p60v-src do not phosphorylate cellular proteins of 120-150 kDa.
    Wendler PA; Boschelli F
    Oncogene; 1989 Feb; 4(2):231-6. PubMed ID: 2494631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo suppression of osteoclast function by adenovirus vector-induced csk gene.
    Miyazaki T; Takayanagi H; Isshiki M; Takahashi T; Okada M; Fukui Y; Oda H; Nakamura K; Hirai H; Kurokawa T; Tanaka S
    J Bone Miner Res; 2000 Jan; 15(1):41-51. PubMed ID: 10646113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential positive and negative autoregulation of p60c-src by intermolecular autophosphorylation.
    Cooper JA; MacAuley A
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4232-6. PubMed ID: 2454466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.